A Novel Missense Mutation in Peripheral Myelin Protein-22 Causes Charcot-Marie-Tooth Disease

Background:Charcot-Marie-Tooth disease (CMT) is the most common inherited peripheral neuropathy.A great number of causative genes have been described in CMT,and among them,the heterozygous duplication of peripheral myelin protein-22 (PMP22) is the major cause.Although the missense mutation in PMP22...

Full description

Saved in:
Bibliographic Details
Published inChinese medical journal Vol. 130; no. 15; pp. 1779 - 1784
Main Authors Li, Li-Xi, Dong, Hai-Lin, Xiao, Bao-Guo, Wu, Zhi-Ying
Format Journal Article
LanguageEnglish
Published China Medknow Publications and Media Pvt. Ltd 05.08.2017
Lippincott Williams & Wilkins Ovid Technologies
Department of Neurology and Institute of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China%Department of Neurology and Research Center of Neurology in Second Affiliated Hospital, The Collaborative Innovation Center for Brain Science, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China
Medknow Publications & Media Pvt Ltd
Wolters Kluwer
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background:Charcot-Marie-Tooth disease (CMT) is the most common inherited peripheral neuropathy.A great number of causative genes have been described in CMT,and among them,the heterozygous duplication of peripheral myelin protein-22 (PMP22) is the major cause.Although the missense mutation in PMP22 is rarely reported,it has been demonstrated to be associated with CMT.This study described a novel missense mutation of PMP22 in a Chinese family with CMT phenotype.Methods:Targeted next-generation sequencing (NGS) was used to screen the causative genes in a family featured with an autosomal dominant demyelinating form of CMT.The potential variants identified by targeted NGS were verified by Sanger sequencing and classified according to the American College of Medical Genetics and Genomics standards and guidelines.Further cell transfection studies were performed to characterize the function of the novel variant.Results:Using targeted NGS,a novel heterozygous missense variant in PMP22 (c.320G〉A,p.G107D) was identified.In vitro cell functional studies revealed that mutant PMP22 protein carrying p.G 107D mutation lost the ability to reach the plasma membrane,was mainly retained in the endoplasmic reticulum,and induced cell apoptosis.Conclusions:This study supported the notion that missense mutations in PMP22 give rise to a CMT phenotype,possibly through a toxic gain-of-function mechanism.
Bibliography:Apoptosis; Charcot-Marie-Tooth Disease; Endoplasmic Reticulum; Missense Mutation; Peripheral Myelin Protein-22
Background:Charcot-Marie-Tooth disease (CMT) is the most common inherited peripheral neuropathy.A great number of causative genes have been described in CMT,and among them,the heterozygous duplication of peripheral myelin protein-22 (PMP22) is the major cause.Although the missense mutation in PMP22 is rarely reported,it has been demonstrated to be associated with CMT.This study described a novel missense mutation of PMP22 in a Chinese family with CMT phenotype.Methods:Targeted next-generation sequencing (NGS) was used to screen the causative genes in a family featured with an autosomal dominant demyelinating form of CMT.The potential variants identified by targeted NGS were verified by Sanger sequencing and classified according to the American College of Medical Genetics and Genomics standards and guidelines.Further cell transfection studies were performed to characterize the function of the novel variant.Results:Using targeted NGS,a novel heterozygous missense variant in PMP22 (c.320G〉A,p.G107D) was identified.In vitro cell functional studies revealed that mutant PMP22 protein carrying p.G 107D mutation lost the ability to reach the plasma membrane,was mainly retained in the endoplasmic reticulum,and induced cell apoptosis.Conclusions:This study supported the notion that missense mutations in PMP22 give rise to a CMT phenotype,possibly through a toxic gain-of-function mechanism.
11-2154/R
ISSN:0366-6999
2542-5641
DOI:10.4103/0366-6999.211539